How to buy Probiotec (PBP) shares

Learn how to easily invest in Probiotec shares.

Probiotec
AU: PBP - AUD
A$2.22
+ A$0.04 ( + 1.83%)
DRUG MANUFACTURERS-SPECIALTY & GENERIC

We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!

Probiotec Limited is a drug manufacturers-specialty & generic business based in Australia. Probiotec shares (PBP) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Probiotec has a trailing 12-month revenue of around $120.5 million. If you're looking to buy shares, check out the steps below.

How to buy shares in Probiotec

  1. Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
  3. Search for Probiotec . Find the share by name or ticker symbol: PBP. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Probiotec reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
  6. Check in on your investment. Congratulations, you own a part of Probiotec . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Probiotec stock price (ASX:PBP)

Use our graph to track the performance of PBP stocks over time.

Probiotec shares at a glance

Information last updated 2021-12-04.
52-week range$1.8887 - $2.4436
50-day moving average $2.162
200-day moving average $2.134
Target price$2.9
PE ratio 36.3934
Dividend yield $0.05 (2.29%)
Earnings per share (TTM) $0.061

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Name Product Standard brokerage fee Inactivity fee Markets
IG Share Trading
AUD $8 or 0.1%
$50 per quarter if you make fewer than three trades in that period
ASX shares, Global shares
$0 brokerage for US and global shares plus get an active trader discount of $5 commission on Australian shares.
Enjoy some of the lowest brokerage fees on the market when trading Australian shares, international shares, plus get access to 24-hour customer support.
Superhero share trading
$5
No
ASX shares, US shares
Earn up to 15,000 Qantas frequent flyer points when you transfer an exisiting balance or trade. Offer valid for all new and existing Superhero members until 28 February.
Pay zero brokerage on US stocks and all ETFs and just $5 (flat fee) to trade Australian shares from your mobile or desktop.
ThinkMarkets Share Trading
AUD $8
No
ASX shares
Limited-time offer: Get 10 free ASX trades ($0 brokerage) when you open a share trading account with ThinkMarkets before 31 December 2021(T&Cs apply). $8 flat fee brokerage for CHESS Sponsored ASX stocks (HIN ownership), plus free live stock price data on an easy to use mobile app.
Bell Direct Share Trading
AUD $15
No
ASX shares, mFunds, ETFs
Finder Exclusive: Get 5 free stock trades and unlimited ETF trades until 31 Dec 2021, when you join Bell Direct. T&Cs apply.
Bell Direct offers a one-second placement guarantee on market-to-limit ASX orders or your trade is free, plus enjoy extensive free research reports from top financial experts.
Saxo Capital Markets (Classic account)
AUD $5
No
ASX shares, Global shares, ETFs
Access 19,000+ stocks on 40+ exchanges worldwide
Low fees for Australian and global share trading, no inactivity fees, low currency conversion fee and optimised for mobile.
loading

Compare up to 4 providers

Is it a good time to buy Probiotec stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Probiotec price performance over time

Historical closes compared with the last close of A$2.22

1 week (2021-11-25) 1.83%
1 month (2021-11-05) 4.72%
3 months (2021-09-03) 0.91%
6 months (2021-06-04) 13.27%
1 year (2020-12-04) -6.72%
2 years (2019-12-05) 18.09%
3 years (2018-12-05) 50.00%
5 years (2016-12-05) 404.55%

Is Probiotec under- or over-valued?

Valuing Probiotec stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Probiotec 's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Probiotec 's P/E ratio

Probiotec 's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 36x. In other words, Probiotec shares trade at around 36x recent earnings.

That's relatively high compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Probiotec 's EBITDA

Probiotec 's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $15.5 million (£0.0 million).

The EBITDA is a measure of a Probiotec 's overall financial performance and is widely used to measure a its profitability.

Probiotec financials

Revenue TTM $120.5 million
Operating margin TTM 9.15%
Gross profit TTM $38.7 million
Return on assets TTM 3.78%
Return on equity TTM 7.85%
Profit margin 4.02%
Book value 0.874
Market capitalisation $167.9 million

TTM: trailing 12 months

Probiotec share dividends

71%

Dividend payout ratio: 71.43% of net profits

Recently Probiotec has paid out, on average, around 71.43% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.25% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Probiotec shareholders could enjoy a 2.25% return on their shares, in the form of dividend payments. In Probiotec 's case, that would currently equate to about A$0.05 per share.

Probiotec 's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.

The latest dividend was paid out to all shareholders who bought their shares by 29 September 2021 (the "ex-dividend date").

Probiotec share price volatility

Over the last 12 months, Probiotec 's shares have ranged in value from as little as $1.8887 up to $2.4436. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Probiotec 's is 0.4791. This would suggest that Probiotec 's shares are less volatile than average (for this exchange).

Probiotec overview

Probiotec Limited engages in the development, manufacture, packing, and sale of pharmaceuticals, consumer health, and fast moving consumer products in Australia and internationally. The company provides contract manufacturing services for solid dose tablets, capsules, and caplets; tablets coating; blister packing; liquids, creams, gels, ointments, and suspensions; powders and powder blending; and sprays, as well as manufactures and packages finished doses. It also offers analytical and stability testing services; new product formulation and production trials, and ongoing research and development services; and packaging options for human and animal nutrition products, as well as manufactures and exports a range of nutraceuticals and functional ingredient raw materials. In addition, the company provides packing services pharmaceutical, consumer, healthcare, cosmetics, and food and beverage companies. Probiotec Limited was incorporated in 1996 and is headquartered in Laverton North, Australia.

Probiotec in the news

There are no recent company news

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Ask an Expert

You are about to post a question on finder.com.au:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com.au is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms of Use, Disclaimer & Privacy Policy and Privacy & Cookies Policy.
Go to site